US equities
|
SPCX
$167.04
▲+5.09%
NVDA
$237.21
▲+1.39%
MU
$1,065.74
▼-0.85%
TSLA
$377.62
▲+1.90%
MSFT
$525.35
▲+1.51%
INTC
$116.48
▼-2.39%
SNDK
$1,713.28
▼-0.39%
META
$745.78
▲+2.43%
SPCX
$167.04
▲+5.09%
NVDA
$237.21
▲+1.39%
MU
$1,065.74
▼-0.85%
TSLA
$377.62
▲+1.90%
MSFT
$525.35
▲+1.51%
INTC
$116.48
▼-2.39%
SNDK
$1,713.28
▼-0.39%
META
$745.78
▲+2.43%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Instil Bio, Inc.
(NQ:
TIL
)
7.220
UNCHANGED
Delayed Quote
Updated: 10:29 AM EDT, Oct 5, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Instil Bio, Inc.
< Previous
1
2
3
4
5
6
Next >
At a Recent Cancer Research Conference, Instil Bio Stole the Show
↗
April 29, 2021
The clinical-stage cell therapy company reported impressive response rates for its candidate treatment against metastatic melanoma.
Via
The Motley Fool
The Daily Biotech Pulse: Quidel Slides On Negative Pre-Announcement, Roche Gets Positive EMA Committee Recommendation, 3 IPOs
↗
April 23, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 22) AtriCure, Inc. (NASDAQ:...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
↗
April 21, 2021
Gainers Alterity Therapeutics (NASDAQ:ATHE) shares rose 17.59% to $1.47 during Wednesday's regular session. As of 12:31 EST, this security is trading at a volume of 55...
Via
Benzinga
The Daily Biotech Pulse: KemPharm Receives $10M Milestone Payment, Zymergen, Neuropace Debut On Nasdaq, Renalytix Wins US Government Contract, 2 IPOs
↗
April 22, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 21) Alexion Pharmaceuticals,...
Via
Benzinga
The Daily Biotech Pulse: Precision Biosciences Regains Rights To CAR T Candidates, CFO Changes, 2 IPOs
↗
April 16, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 15) Ardelyx, Inc. (NASDAQ:...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 13, 2021
↗
April 13, 2021
Upgrades For Booking Holdings Inc (NASDAQ:BKNG), Jefferies upgraded the previous rating of Hold to Buy. In the fourth quarter, Booking Holdings showed an EPS of $0.57,...
Via
Benzinga
The Week Ahead In Biotech (April 11-17): Avenue Therapeutics FDA Decision and Conference Presentations In The Spotlight
↗
April 10, 2021
Contrary to the strength in the broader market, biotech stocks ended the week ending April 9 lower. The weakness partly reflected a preference for risky bets at the expense of...
Via
Benzinga
The Daily Biotech Pulse: Leadership Transition At Amarin, Vaccine Setback For J&J, FDA Nod For Label Expansion of Roche's Asthma Drug
↗
April 13, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 12) 180 Life Sciences Corp. (...
Via
Benzinga
The Daily Biotech Pulse: Negative Regulatory Tidings For Provention Bio, Celcuity Soars On In-licensing Deal, 2 IPOs
↗
April 09, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 8) Aclaris Therapeutics, Inc...
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
